A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 23,059 shares of CRL stock, worth $4.76 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
23,059
Previous 16,966 35.91%
Holding current value
$4.76 Million
Previous $4.01 Million 55.79%
% of portfolio
0.1%
Previous 0.08%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$203.52 - $273.43 $1.24 Million - $1.67 Million
6,093 Added 35.91%
23,059 $6.25 Million
Q4 2023

Feb 14, 2024

BUY
$164.52 - $238.84 $146,258 - $212,328
889 Added 5.53%
16,966 $4.01 Million
Q3 2023

Nov 14, 2023

BUY
$194.44 - $217.61 $358,547 - $401,272
1,844 Added 12.96%
16,077 $3.15 Million
Q2 2023

Aug 14, 2023

SELL
$183.71 - $210.25 $336,556 - $385,178
-1,832 Reduced 11.4%
14,233 $2.99 Million
Q1 2023

May 15, 2023

BUY
$191.89 - $259.92 $628,247 - $850,978
3,274 Added 25.6%
16,065 $3.24 Million
Q4 2022

Feb 14, 2023

SELL
$197.11 - $250.07 $535,744 - $679,690
-2,718 Reduced 17.53%
12,791 $2.79 Million
Q3 2022

Nov 14, 2022

SELL
$182.44 - $250.54 $285,153 - $391,594
-1,563 Reduced 9.16%
15,509 $3.05 Million
Q2 2022

Aug 15, 2022

SELL
$204.13 - $302.4 $431,122 - $638,668
-2,112 Reduced 11.01%
17,072 $3.65 Million
Q1 2022

May 16, 2022

BUY
$255.51 - $362.11 $3.67 Million - $5.2 Million
14,360 Added 297.68%
19,184 $5.45 Million
Q4 2021

Feb 14, 2022

SELL
$351.38 - $448.68 $609,292 - $778,011
-1,734 Reduced 26.44%
4,824 $1.82 Million
Q3 2021

Nov 15, 2021

BUY
$372.64 - $458.3 $472,507 - $581,124
1,268 Added 23.97%
6,558 $2.71 Million
Q2 2021

Aug 16, 2021

BUY
$294.17 - $371.65 $515,680 - $651,502
1,753 Added 49.56%
5,290 $1.96 Million
Q1 2021

May 17, 2021

SELL
$249.67 - $299.48 $863,109 - $1.04 Million
-3,457 Reduced 49.43%
3,537 $1.03 Million
Q4 2020

Feb 16, 2021

SELL
$222.0 - $252.62 $836,718 - $952,124
-3,769 Reduced 35.02%
6,994 $1.75 Million
Q3 2020

Nov 16, 2020

BUY
$175.56 - $226.45 $411,161 - $530,345
2,342 Added 27.81%
10,763 $2.44 Million
Q2 2020

Aug 13, 2020

SELL
$118.84 - $189.72 $2.38 Million - $3.81 Million
-20,059 Reduced 70.43%
8,421 $1.47 Million
Q1 2020

May 15, 2020

BUY
$98.9 - $178.34 $2.64 Million - $4.76 Million
26,665 Added 1469.15%
28,480 $3.59 Million
Q4 2019

Feb 14, 2020

BUY
$126.05 - $152.76 $228,780 - $277,259
1,815 New
1,815 $277,000
Q3 2019

Nov 14, 2019

SELL
$125.07 - $143.67 $281,157 - $322,970
-2,248 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$123.4 - $148.55 $970,294 - $1.17 Million
-7,863 Reduced 77.77%
2,248 $319,000
Q1 2019

May 15, 2019

SELL
$104.82 - $146.73 $2.49 Million - $3.49 Million
-23,794 Reduced 70.18%
10,111 $1.47 Million
Q4 2018

Feb 14, 2019

BUY
$105.09 - $137.23 $3.56 Million - $4.65 Million
33,905 New
33,905 $3.84 Million
Q2 2018

Aug 14, 2018

SELL
$102.37 - $117.25 $281,517 - $322,437
-2,750 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$98.19 - $115.2 $270,022 - $316,800
2,750 New
2,750 $294,000
Q4 2017

Feb 14, 2018

SELL
$100.43 - $118.09 $4.61 Million - $5.42 Million
-45,906 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$96.72 - $109.26 $4.44 Million - $5.02 Million
45,906
45,906 $4.96 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.5B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.